{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:57:24Z","timestamp":1783414644445,"version":"3.54.6"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072853"],"award-info":[{"award-number":["82072853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Endocervical adenocarcinoma (ECA) is reported increasingly often in young women, and this aggressive disease lacks effective methods of targeted therapy. Since mismatch repair deficiency (dMMR) is an important biomarker for predicting response to immune checkpoint inhibitors, it is important to investigate the clinicopathological features and immune microenvironment of dMMR ECAs. We assessed 617 ECAs from representative tissue microarray sections, gathered clinicopathologic information, reviewed histological characteristics, and performed immunohistochemical staining for MMR, programmed cell death 1 (PD-L1), and other immune markers. Of 617 ECA samples, 20 (3.2%) cases had dMMR. Among them, loss of MMR-related proteins expression was observed in 17\/562 (3.0%) human papilloma virus-associated (HPVA) adenocarcinoma and 3\/55 (5.5%) non-HPV-associated (NHPVA) adenocarcinoma. In NHPVA cohort, dMMR status was observed in 3 (3\/14, 15.0%) patients with clear cells. dMMR ECAs had a higher tendency to have a family history of cancer, larger tumor size, p16 negative, HPV E6\/E7 mRNA in situ hybridization (HPV E6\/E7 RNAscope) negative, and lower ki-67 index. Among the morphological variables evaluated, poor differentiation, necrosis, stromal tumor-infiltrating lymphocytes, peritumoral lymphocytes, and lymphoid follicles were easily recognized in the dMMR ECAs. In addition, dMMR ECAs had higher CD3+, CD8+, CD38+, CD68+ and PD-1+ immune cells. A relatively high prevalence of PD-L1 expression was observed in dMMR ECAs. dMMR ECAs were significantly more likely to present with a tumor-infiltrating lymphocytes -high\/PD-L1-positive status. In conclusion, dMMR ECAs have some specific morphological features and a critical impact on the immune microenvironment, which may provide insights into improving responses to immunotherapy-included comprehensive treatment for ECAs in the future.<\/jats:p>","DOI":"10.1093\/oncolo\/oyae192","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:06:04Z","timestamp":1723075564000},"page":"e1302-e1314","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathological and immune characterization of mismatch repair deficient endocervical adenocarcinoma"],"prefix":"10.1093","volume":"29","author":[{"given":"Ying-Wen","family":"Wu","sequence":"first","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Guangdong Sanjiu Brain Hospital , Guangzhou ,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Wei","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yu","family":"Liang","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Yan","family":"Cai","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Zhen","family":"Luo","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-2038","authenticated-orcid":false,"given":"Li-Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center , Guangzhou 510060 ,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"issue":"2","key":"2024100317270120100_CIT0001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2024100317270120100_CIT0002","volume-title":"Female Genital Tumours","author":"World Health Organization classification of tumours","year":"2020","edition":"5"},{"issue":"28","key":"2024100317270120100_CIT0003","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2009.21.8909","article-title":"Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study","volume":"27","author":"Monk","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"2024100317270120100_CIT0004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrm1907","article-title":"The multifaceted mismatch-repair system","volume":"7","author":"Jiricny","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2024100317270120100_CIT0005","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1038\/s41467-019-11530-0","article-title":"Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients","volume":"10","author":"Serebriiskii","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"2024100317270120100_CIT0006","first-page":"PO.17.00073","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"26","key":"2024100317270120100_CIT0007","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med."},{"issue":"1","key":"2024100317270120100_CIT0008","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2007.04.044","article-title":"Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study","volume":"133","author":"Jenkins","year":"2007","journal-title":"Gastroenterology"},{"issue":"7","key":"2024100317270120100_CIT0009","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/PAS.0000000000001692","article-title":"Morphology matters: a critical reappraisal of the clinical relevance of morphologic criteria from the 2019 WHO classification in a large colorectal cancer cohort comprising 1004 cases","volume":"45","author":"Jesinghaus","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2024100317270120100_CIT0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/bjc.2015.213","article-title":"Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis","volume":"113","author":"De Smedt","year":"2015","journal-title":"Br J Cancer."},{"issue":"3","key":"2024100317270120100_CIT0011","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/hupa.2002.32220","article-title":"Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma","volume":"33","author":"Peiro","year":"2002","journal-title":"Hum Pathol"},{"issue":"1","key":"2024100317270120100_CIT0012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2007.05.022","article-title":"Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer","volume":"39","author":"Shia","year":"2008","journal-title":"Hum Pathol"},{"issue":"September","key":"2024100317270120100_CIT0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","article-title":"DNA mismatch repair in cancer","volume":"189","author":"Baretti","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"6","key":"2024100317270120100_CIT0014","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00292-018-0507-x","article-title":"[Predictive value of PD-L1 diagnostics]","volume":"39","author":"Schildhaus","year":"2018","journal-title":"Pathologe"},{"issue":"2","key":"2024100317270120100_CIT0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0000000000000986","article-title":"International Endocervical Adenocarcinoma Criteria and Classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2024100317270120100_CIT0016","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s12935-021-02349-1","article-title":"HPV E6\/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis","volume":"21","author":"Luo","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"5","key":"2024100317270120100_CIT0017","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/PAS.0000000000000402","article-title":"Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance","volume":"39","author":"Roma","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2024100317270120100_CIT0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/COC.0000000000000798","article-title":"Tumor necrotic debris and high nuclear grade: newly identified high-risk factors for early-stage endocervical adenocarcinoma","volume":"44","author":"Holloway","year":"2021","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"2024100317270120100_CIT0019","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1309\/AJCPSUQVIGA8S1AH","article-title":"Medullary-like hepatocellular carcinoma: an unusual histologic variant","volume":"142","author":"Quist","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"2024100317270120100_CIT0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00000478-200311000-00002","article-title":"Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer","volume":"27","author":"Shia","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2024100317270120100_CIT0021","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/PGP.0b013e31824a1dad","article-title":"Are women with endocervical adenocarcinoma at risk for lynch syndrome? Evaluation of 101 cases including unusual subtypes and lower uterine segment tumors","volume":"31","author":"Mills","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"2024100317270120100_CIT0022","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0000000000000578","article-title":"A detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas","volume":"40","author":"Carleton","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2024100317270120100_CIT0023","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/his.14435","article-title":"PD-L1 expression and immune stromal features in HPV-independent cervical adenocarcinoma","volume":"79","author":"Song","year":"2021","journal-title":"Histopathology"},{"issue":"3","key":"2024100317270120100_CIT0024","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<507::AID-CNCR12>3.0.CO;2-8","article-title":"Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero","volume":"77","author":"Boyd","year":"1996","journal-title":"Cancer"},{"issue":"6","key":"2024100317270120100_CIT0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/PAS.0000000000001863","article-title":"Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent tumor associated with poor outcome: a comprehensive analysis of 58 cases","volume":"46","author":"Stolnicu","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2024100317270120100_CIT0026","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","article-title":"Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma","volume":"24","author":"Black","year":"2006","journal-title":"J Clin Oncol."},{"issue":"1","key":"2024100317270120100_CIT0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"issue":"6","key":"2024100317270120100_CIT0028","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.pas.0000126720.49083.11","article-title":"More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon","volume":"28","author":"van den Bos","year":"2004","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"2024100317270120100_CIT0029","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U","article-title":"Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma","volume":"91","author":"Smyrk","year":"2001","journal-title":"Cancer"},{"issue":"5795","key":"2024100317270120100_CIT0030","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science (New York, NY)"},{"issue":"3","key":"2024100317270120100_CIT0031","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jcp.2005.028860","article-title":"Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions","volume":"59","author":"Hussein","year":"2006","journal-title":"J Clin Pathol"},{"issue":"9","key":"2024100317270120100_CIT0032","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.bjc.6602201","article-title":"Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis","volume":"91","author":"Chiba","year":"2004","journal-title":"Br J Cancer"},{"issue":"4","key":"2024100317270120100_CIT0033","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/modpathol.2016.198","article-title":"Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications","volume":"30","author":"Shia","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"2024100317270120100_CIT0034","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-18-0856","article-title":"Immune activation in mismatch repair-deficient carcinogenesis: more than just mutational rate","volume":"26","author":"Willis","year":"2020","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2024100317270120100_CIT0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2024100317270120100_CIT0036","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bjc.2016.17","article-title":"Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment","volume":"114","author":"Park","year":"2016","journal-title":"Br J Cancer"},{"issue":"2018","key":"2024100317270120100_CIT0037","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.humpath.2017.09.019","article-title":"Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells","volume":"72","author":"Le Flahec","year":"2018","journal-title":"Hum Pathol"},{"issue":"49","key":"2024100317270120100_CIT0038","doi-asserted-by":"crossref","first-page":"85526","DOI":"10.18632\/oncotarget.20241","article-title":"Impact of mismatch-repair deficiency on the colorectal cancer immune microenvironment","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"2021","key":"2024100317270120100_CIT0039","doi-asserted-by":"crossref","first-page":"640018","DOI":"10.3389\/fonc.2021.640018","article-title":"POLE and mismatch repair status, checkpoint proteins and tumor-infiltrating lymphocytes in combination, and tumor differentiation: identify endometrial cancers for immunotherapy","volume":"11","author":"Dong","year":"2021","journal-title":"Front Oncol"},{"issue":"9","key":"2024100317270120100_CIT0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncol"},{"issue":"3","key":"2024100317270120100_CIT0041","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/PAS.0000000000001800","article-title":"The prognostic values of HPV genotypes and tumor PD-L1 expression in patients with HPV-associated endocervical adenocarcinoma","volume":"46","author":"Zhou","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2024100317270120100_CIT0042","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/PAS.0000000000001633","article-title":"PD-L1 expression in endocervical adenocarcinoma: correlation with patterns of tumor invasion, CD8+ tumor-infiltrating lymphocytes, and clinical outcomes","volume":"45","author":"Rivera-Colon","year":"2021","journal-title":"Am J Surg Pathol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/10\/e1302\/59558270\/oyae192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/10\/e1302\/59558270\/oyae192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T17:33:43Z","timestamp":1727976823000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/10\/e1302\/7729222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,8,7]]},"published-print":{"date-parts":[[2024,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyae192","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,8,7]]}}}